Raschi, Emanuel; Poluzzi, Elisabetta; Ponti, Fabrizio De, QT prolongation with anticancer drugs: a multimodal issue, «THE LANCET ONCOLOGY», 2022, 23, pp. 522 - 522 [Comment or similar]
Raschi E.; Fusaroli M.; La Placa M.; Ardizzoni A.; Zamagni C.; Poluzzi E.; De Ponti F., Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System, «AMERICAN JOURNAL OF CLINICAL DERMATOLOGY», 2022, 23, pp. 247 - 255 [Scientific article]
Lunghi C.; Trevisan C.; Fusaroli M.; Giunchi V.; Raschi E.; Sangiorgi E.; Domenicali M.; Volpato S.; De Ponti F.; Poluzzi E., Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People, «PHARMACEUTICALS», 2022, 15, Article number: 977 , pp. 1 - 15 [Scientific article]Open Access
Bakkum, Michiel J; Loobeek, Bryan J; Richir, Milan C; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; Dima, Lorena; de Ponti, Fabrizio; Kramers, Cornelis; van Smeden, Jeroen; van Agtmael, Michiel A; Tichelaar, Jelle, Teaching resources for the European Open Platform for Prescribing Education (EurOP2E)-a nominal group technique study, «CLINICAL PHARMACOLOGY & THERAPEUTICS», 2022, 7, pp. 1 - 7 [Scientific article]
Donker, Erik M; Brinkman, David J; Richir, Milan C; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; De Ponti, Fabrizio; Böttiger, Ylva; Kramers, Cornelis; van Agtmael, Michiel A; Tichelaar, Jelle, The European Prescribing Exam: assessing whether European medical students can prescribe rationally and safely, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2022, 78, pp. 1049 - 1051 [Comment or similar]
Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi, Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system, «EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY», 2021, 28, Article number: 2047487320915663 , pp. 983 - 989 [Scientific article]Open Access
Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems, «CLINICAL NUTRITION», 2021, 40, pp. 1176 - 1185 [Scientific article]
Gatti, Milo; Giannella, Maddalena; Raschi, Emanuel; Viale, Pierluigi; De Ponti, Fabrizio, Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2021, 76, pp. 199 - 205 [Scientific article]
Gatti M.; De Ponti F.; Pea F., Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies, «CNS DRUGS», 2021, 35, pp. 345 - 384 [Scientific article]Open Access
Raschi E.; Fusaroli M.; Ardizzoni A.; Poluzzi E.; De Ponti F., Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment, «BREAST CANCER RESEARCH AND TREATMENT», 2021, 186, pp. 219 - 227 [Scientific article]Open Access
Lee Y.-M.; Cao K.; Leech M.; De Ponti F., Developing medical artificial intelligence leaders: International university consortium approach, «MEDICAL EDUCATION», 2021, 55, pp. 1321 - 1322 [Scientific article]
Fusaroli M.; Raschi E.; Gatti M.; De Ponti F.; Poluzzi E., Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 740707 , pp. 1 - 11 [Scientific article]Open Access
Gatti M.; De Ponti F., Drug Interactions with Contraceptives, in: Trends in Andrology and Sexual Medicine, Berlino, Springer Science and Business Media Deutschland GmbH, 2021, pp. 325 - 359 (TRENDS IN ANDROLOGY AND SEXUAL MEDICINE) [Chapter or essay]
Gatti M.; De Ponti F., Drug repurposing in the covid-19 era: Insights from case studies showing pharmaceutical peculiarities, «PHARMACEUTICS», 2021, 13, Article number: 302 , pp. 1 - 23 [Scientific article]Open Access
Raschi E.; Antonazzo I.C.; Poluzzi E.; De Ponti F., Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list?, «ANNALS OF THE RHEUMATIC DISEASES», 2021, 80, pp. 120 - 120 [Comment or similar]
